Diagnosis and assessment of systemic vasculitis. by McLaren, J, McRorie, E, Luqmani, R

Rheumatoid constrictive pericarditis. by McRorie, E, Wright, R, Errington, M, Luqmani, R

Rheumatoid constrictive pericarditis by McRorie, E, Wright, R, Errington, M, Luqmani, R

Rheumatoid constrictive pericarditis. by McRorie, E, Wright, R, Errington, M, Luqmani, R

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hos... by McLaren, J, Stimson, R, McRorie, E, Coia, J, Luqmani, R

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting by McLaren, J, Stimson, R, McRorie, E, Coia, J, Luqmani, R

The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. by McLaren, J, Stimson, R, McRorie, E, Coia, J, Luqmani, R

Damage is independent of disease activity in systemic vasculitis by McRorie, E, Luqmani, R, Dadoniene, J, Rychlik, I, Tesar, V, Nowack, R

The vasculitis damage index as a surrogate outcome measure in systemic vasculitis. by McRorie, E, McGill, A, Plant, W, Fleming, S, Adams, W, Craig, K, Luqmani, R

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferi... by Porter, D, van Melckebeke, J, Dale, J, Messow, C, McConnachie, A, Walker, A, Munro, R, McLaren, J, McRorie, E, Packham, J, Buckley, C, Harvie, J, Taylor, P, Choy, E, Pitzalis, C, McInnes, I

Optimal management of RA patients who require Biologic Therapy (ORBIT) – a randomised controlled, non-inferiority study by Porter, D, van Melckebeke, J, Dale, J, Messow, C, McConnachie, P, Walker, A, Munro, R, McLaren, J, McRorie, E, Packham, J, Buckley, C, Harvie, J, Pitzalis, C, Taylor, P, Choy, E, McInnes, I